馬尿酸

Solid; [Merck Index] White crystalline powder; [Alfa Aesar MSDS]

Solid

139.72 Ų [M-H]- [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]

142 Ų [M-H]- [CCS Type: DT; Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]；149.6 Ų [M+Na]+ [CCS Type: DT; Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]

146.82 Ų [M+H]+ [CCS Type: DT; Method: stepped-field]；148.23 Ų [M-H]- [CCS Type: DT; Method: stepped-field]；154.06 Ų [M+Na]+ [CCS Type: DT; Method: stepped-field]

149.9 Ų [M+Na]+；147.7 Ų [M-H]-；153.1 Ų [M+Na]+；145.9 Ų [M+H]+；142.4 Ų [M-H]-

This chemical does not meet GHS hazard criteria for 5.2% (3 of 58) of reports.

Danger

H302 (93.1%): Harmful if swallowed [Warning Acute toxicity, oral]；H315 (94.8%): Causes skin irritation [Warning Skin corrosion/irritation]；H318 (93.1%): Causes serious eye damage [Danger Serious eye damage/eye irritation]；H335 (93.1%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]

P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P354+P338, P317, P319, P321, P330, P332+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 58 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.；Reported as not meeting GHS hazard criteria per 3 of 58 reports by companies.；There are 7 notifications provided by 55 of 58 reports by companies with hazard statement code(s).；Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

Chemical: Glycine, N-benzoyl-

Status: Active Update: 03-09-2021 https://echa.europa.eu/registration-dossier/-/registered-dossier/19668

Glycine, N-benzoyl-: Does not have an individual approval but may be used under an appropriate group standard

The glycine conjugate of benzoic acid and a human metabolite of toluene; Has been measured in urine as an indicator of occupational exposure to toluene (in the absence of xylene and styrene exposure); [NIOSH Manual of Analytical Methods] May cause irritation; [Alfa Aesar MSDS]

Uremic toxins such as hippuric acid are actively transported into the kidneys via organic ion transporters (especially OAT3). Increased levels of uremic toxins can stimulate the production of reactive oxygen species. This seems to be mediated by the direct binding or inhibition by uremic toxins of the enzyme NADPH oxidase (especially NOX4 which is abundant in the kidneys and heart) (A7868). Reactive oxygen species can induce several different DNA methyltransferases (DNMTs) which are involved in the silencing of a protein known as KLOTHO. KLOTHO has been identified as having important roles in anti-aging, mineral metabolism, and vitamin D metabolism. A number of studies have indicated that KLOTHO mRNA and protein levels are reduced during acute or chronic kidney diseases in response to high local levels of reactive oxygen species (A7869).

As a uremic toxin, this compound can cause uremic syndrome. Uremic syndrome may affect any part of the body and can cause nausea, vomiting, loss of appetite, and weight loss. It can also cause changes in mental status, such as confusion, reduced awareness, agitation, psychosis, seizures, and coma. Abnormal bleeding, such as bleeding spontaneously or profusely from a very minor injury can also occur. Heart problems, such as an irregular heartbeat, inflammation in the sac that surrounds the heart (pericarditis), and increased pressure on the heart can be seen in patients with uremic syndrome. Shortness of breath from fluid buildup in the space between the lungs and the chest wall (pleural effusion) can also be present.

Chemical: Glycine, N-benzoyl-

Status: Active Update: 03-09-2021 https://echa.europa.eu/registration-dossier/-/registered-dossier/19668

Glycine, N-benzoyl-: Does not have an individual approval but may be used under an appropriate group standard

Found in the urine of herbivorous animals and humans; [Merck Index]

Naturally produced by the body (endogenous).